Trial Profile
To Evaluate tolerability and short term survival of adjuvant chemotherapy with oral vinorelbine used in doublet with carboplatin in patients with non-small cell lung cancer after radical resection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 15 Dec 2015 New trial record